EU willing to discuss COVID-19 vaccine patent waiver: EU’s von der Leyen
© Reuters. FILE PHOTO: European Commission President Ursula von der Leyen takes off her mask as she meets with Jordanian King Abdullah II Ibn Al Hussein (not pictured) on May 5, 2021 in Brussels, Belgium. REUTERS / Yves Herman / Pool
BRUSSELS (Reuters) – The European Union stands ready to discuss a now US-backed proposal to waive intellectual property rights for COVID-19 vaccines, European Commission President Ursula von der Leyen said Thursday .
“The EU is also ready to discuss proposals that will address the crisis effectively and pragmatically,” she said in a speech to the European University Institute in Florence.
“So we stand ready to discuss how the US proposal to remove intellectual property protection for COVID-19 vaccines could help achieve this goal.”
Disclaimer: Fusion Media would like to remind you that the information contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and forex prices are not provided by exchanges, but by market makers. Therefore, prices may not be accurate and may differ from the actual market price. This means that the prices are indicative and not suitable for trading purposes. Therefore, Fusion Media is not responsible for any trading losses you may incur as a result of using this data.
Fusion Media, or anyone involved with Fusion Media, assumes no liability for any loss or damage caused by reliance on the information contained on this website, such as data, offers, charts, and buy / sell signals. Please inform yourself comprehensively about the risks and costs associated with trading in the financial markets. This is one of the riskiest forms of investment possible.